Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Model Based Estimation of the SARS-CoV-2 Immunization Level in Austria and Consequences for Herd Immunity Effects

View ORCID ProfileMartin Bicher, View ORCID ProfileClaire Rippinger, View ORCID ProfileGünter Schneckenreither, Nadine Weibrecht, View ORCID ProfileChristoph Urach, Melanie Zechmeister, View ORCID ProfileDominik Brunmeir, View ORCID ProfileWolfgang Huf, View ORCID ProfileNiki Popper
doi: https://doi.org/10.1101/2021.03.10.21253251
Martin Bicher
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin Bicher
  • For correspondence: martin.bicher@dwh.at
Claire Rippinger
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire Rippinger
Günter Schneckenreither
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Günter Schneckenreither
Nadine Weibrecht
3Association for Decision Support for Health Policy and Planning (DEXHELPP), 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christoph Urach
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christoph Urach
Melanie Zechmeister
3Association for Decision Support for Health Policy and Planning (DEXHELPP), 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominik Brunmeir
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dominik Brunmeir
Wolfgang Huf
4Department of Laboratory Medicine, Vienna Healthcare Group, Hietzing Hospital, Vienna, Austria
5Karl Landsteiner Institute for Clinical Risk Management, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wolfgang Huf
Niki Popper
1Institute for Information Systems Engineering, TU Wien, Vienna, Austria
2DWH Simulation Services, 1070 Vienna, Austria
3Association for Decision Support for Health Policy and Planning (DEXHELPP), 1070 Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Niki Popper
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Several systemic factors indicate, that worldwide herd immunity against COVID-19 will probably not be achieved in 2021. Vaccination programs are limited by availability of doses, the number of people already infected is still too low to have a disease preventing impact and new emerging variants of the virus seem to partially neglect developed antibodies from previous infections. Nevertheless, after one year of COVID-19 observing high numbers of reported cases in most European countries, we might expect that the immunization level should have an impact on the spread of SARS-CoV-2. We used an agent-based simulation model to reproduce the COVID-19 pandemic in Austria to estimate the immunization level of the population as of February 2021. We ran several simulations of an uncontrolled epidemic wave with varying initial immunization scenarios to assess the effect on the effective reproduction number. We also used a classic differential equation SIR-model to cross-validate the simulation model. As of February 2021, 14.7% of the Austrian population has been affected by a SARS-CoV-2 infection which causes a 9% reduction of the effective reproduction number and a 24.7% reduction of the prevalence peak compared to a fully susceptible population. This estimation is now recomputed on a regular basis to publish model based analysis of immunization level in Austria also including the fast growing effects of vaccination programs. This provides substantial information for decision makers to evaluate the necessity of NPI-measures based on the estimated impact of natural and vaccinated immunization.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by the Austrian Research Promotion Agency (FFG) COVID-19 Emergency Call, the Vienna Science and Technology Fund WWTF-COVID-19 Rapid Response Funding, the Medical Scientific Fund of the Mayor of the City of Vienna and the Society for Medical Decision Making (SMDM) COVID-19 Decision Modeling Initiative.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study had no need of any ethics committee approval

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data for the simulated SARS-CoV-2 seroprevalence level in Austria are publicly available and are updated regularly (see Link 1). Data for estimation of the seroprevalence level were drawn from the official Austrian epidemiological reporting system for SARS-CoV-2 (EMS, see Link 2) and the results from (serological and prevalence) randomized screening studies performed in Austria (see Links 3 and 4). Metadata used for parametrization of the simulation model is found the parameter-tables found in the supplemental of publicly available preprint "Evaluation of Contact-Tracing Policies Against the Spread of SARS-CoV-2 in Austria - An Agent-Based Simulation" (Link 5).

http://www.dexhelpp.at/en/immunization_level/

https://covid19-dashboard.ages.at/

https://www.sora.at/nc/news-presse/news/news-einzelansicht/news/covid-19-praevalenz-1006.html

https://www.statistik.at/web_de/statistiken/menschen_und_gesellschaft/gesundheit/covid19/index.html

https://www.medrxiv.org/content/10.1101/2020.05.12.20098970v4

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Model Based Estimation of the SARS-CoV-2 Immunization Level in Austria and Consequences for Herd Immunity Effects
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Model Based Estimation of the SARS-CoV-2 Immunization Level in Austria and Consequences for Herd Immunity Effects
Martin Bicher, Claire Rippinger, Günter Schneckenreither, Nadine Weibrecht, Christoph Urach, Melanie Zechmeister, Dominik Brunmeir, Wolfgang Huf, Niki Popper
medRxiv 2021.03.10.21253251; doi: https://doi.org/10.1101/2021.03.10.21253251
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Model Based Estimation of the SARS-CoV-2 Immunization Level in Austria and Consequences for Herd Immunity Effects
Martin Bicher, Claire Rippinger, Günter Schneckenreither, Nadine Weibrecht, Christoph Urach, Melanie Zechmeister, Dominik Brunmeir, Wolfgang Huf, Niki Popper
medRxiv 2021.03.10.21253251; doi: https://doi.org/10.1101/2021.03.10.21253251

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1244)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (532)
  • Epidemiology (10027)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2462)
  • Geriatric Medicine (238)
  • Health Economics (479)
  • Health Informatics (1645)
  • Health Policy (753)
  • Health Systems and Quality Improvement (636)
  • Hematology (250)
  • HIV/AIDS (535)
  • Infectious Diseases (except HIV/AIDS) (11871)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2289)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1248)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (733)
  • Pharmacology and Therapeutics (314)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4841)
  • Radiology and Imaging (838)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (651)
  • Rheumatology (286)
  • Sexual and Reproductive Health (240)
  • Sports Medicine (227)
  • Surgery (268)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)